BioSpace Movers & Shakers, July 16 biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Published: Jul 13, 2021
VANCOUVER, British Columbia (BUSINESS WIRE) AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, announced today that Neil Berkley has been appointed as Chief Business Officer (CBO). Mr. Berkley’s role will include leading the strategy and continued growth of AbCellera’s partnership business, which currently includes a diverse portfolio of more than 100 programs with drug developers of all sizes.
“Neil brings a wealth of business development experience that will be instrumental as we continue to execute our long-term strategy of using partnerships to accelerate the development of antibody therapeutics for a wide array of diseases,” said Carl Hansen, Ph.D., CEO of AbCellera. “We are excited to welcome Neil to the team and look forward to his leadership in expanding our commercial reach across the globe.”